254 related articles for article (PubMed ID: 1547024)
1. Shigella-specific IgA in saliva of children with bacillary dysentery.
Schultsz C; Qadri F; Hossain SA; Ahmed F; Ciznar I
FEMS Microbiol Immunol; 1992 Jan; 4(2):65-72. PubMed ID: 1547024
[TBL] [Abstract][Full Text] [Related]
2. Mucosal immune response in patients with dysentery.
Ciznar I; Qadri F; Hoque S; Bin AA; Schultsz C; Bartkova G
Adv Exp Med Biol; 1995; 371B():919-22. PubMed ID: 7502926
[No Abstract] [Full Text] [Related]
3. Antibodies to shiga holotoxin and to two synthetic peptides of the B subunit in sera of patients with Shigella dysenteriae 1 dysentery.
Levine MM; McEwen J; Losonsky G; Reymann M; Harari I; Brown JE; Taylor DN; Donohue-Rolfe A; Cohen D; Bennish M
J Clin Microbiol; 1992 Jul; 30(7):1636-41. PubMed ID: 1629317
[TBL] [Abstract][Full Text] [Related]
4. Semiquantitative estimation of Shigella antigen-specific antibodies: correlation with disease severity during shigellosis.
Islam D; Wretlind B; Hammarström L; Christensson B; Lindberg AA
APMIS; 1996; 104(7-8):563-74. PubMed ID: 8920810
[TBL] [Abstract][Full Text] [Related]
5. [The determination in saliva of IgA antibodies to Shigella ribosomes for the diagnosis of dysentery].
Salamatova SA; Sukhoroslova LI; Chernokhvostova EV; Levenson VI
Zh Mikrobiol Epidemiol Immunobiol; 1991 Jun; (6):59-62. PubMed ID: 1887713
[TBL] [Abstract][Full Text] [Related]
6. Detection of antibodies to Shigella lipopolysaccharide in urine after natural Shigella infection or vaccination.
Cohen D; Orr N; Robin G; Slepon R; Ashkenazi S; Ashkenazi I; Shemer J
Clin Diagn Lab Immunol; 1996 Jul; 3(4):451-5. PubMed ID: 8807212
[TBL] [Abstract][Full Text] [Related]
7. Immunoglobulin subclass distribution and dynamics of Shigella-specific antibody responses in serum and stool samples in shigellosis.
Islam D; Wretlind B; Ryd M; Lindberg AA; Christensson B
Infect Immun; 1995 May; 63(5):2054-61. PubMed ID: 7729920
[TBL] [Abstract][Full Text] [Related]
8. Serum antibody responses against shigella lipopolysaccharides and invasion plasmid-coded antigens in shigella infected Swedish patients.
Li A; Rong ZC; Ekwall E; Forsum U; Lindberg AA
Scand J Infect Dis; 1993; 25(5):569-77. PubMed ID: 8284641
[TBL] [Abstract][Full Text] [Related]
9. Shigella lipopolysaccharide antibodies in pediatric populations.
Passwell JH; Freier S; Shor R; Farzam N; Block C; Lison M; Shiff E; Ashkenazi S
Pediatr Infect Dis J; 1995 Oct; 14(10):859-65. PubMed ID: 8584312
[TBL] [Abstract][Full Text] [Related]
10. [An immunoenzyme method for determining IgA antibodies to lipopolysaccharide in secretions in the diagnosis of shigellosis].
Salamatova SA; Sukhoroslova LI; Shalamberidze IA; Brusenina ND
Zh Mikrobiol Epidemiol Immunobiol; 1993; (3):85-9. PubMed ID: 8067099
[TBL] [Abstract][Full Text] [Related]
11. Concentration of milk secretory immunoglobulin A against Shigella virulence plasmid-associated antigens as a predictor of symptom status in Shigella-infected breast-fed infants.
Hayani KC; Guerrero ML; Morrow AL; Gomez HF; Winsor DK; Ruiz-Palacios GM; Cleary TG
J Pediatr; 1992 Dec; 121(6):852-6. PubMed ID: 1447644
[TBL] [Abstract][Full Text] [Related]
12. An approach to chimeric subunit immunogen provides efficient protection against toxicity, type III and type v secretion systems of Shigella.
Felegary A; Nazarian S; Kordbacheh E; Fathi J; Minae ME
Int Immunopharmacol; 2021 Nov; 100():108132. PubMed ID: 34508943
[TBL] [Abstract][Full Text] [Related]
13. Shigellosis in Vietnam: seroepidemiologic studies with use of lipopolysaccharide antigens in enzyme immunoassays.
Lindberg AA; Cam PD; Chan N; Phu LK; Trach DD; Lindberg G; Karlsson K; Kärnell A; Ekwall E
Rev Infect Dis; 1991; 13 Suppl 4():S231-7. PubMed ID: 2047643
[TBL] [Abstract][Full Text] [Related]
14. Predominance of serotype-specific mucosal antibody response in Shigella flexneri-infected humans living in an area of endemicity.
Rasolofo-Razanamparany V; Cassel-Beraud AM; Roux J; Sansonetti PJ; Phalipon A
Infect Immun; 2001 Sep; 69(9):5230-4. PubMed ID: 11500390
[TBL] [Abstract][Full Text] [Related]
15. Prospective study of systemic and mucosal immune responses in dysenteric patients to specific Shigella invasion plasmid antigens and lipopolysaccharides.
Oberhelman RA; Kopecko DJ; Salazar-Lindo E; Gotuzzo E; Buysse JM; Venkatesan MM; Yi A; Fernandez-Prada C; Guzman M; León-Barúa R
Infect Immun; 1991 Jul; 59(7):2341-50. PubMed ID: 2050402
[TBL] [Abstract][Full Text] [Related]
16. Antibody response to lipopolysaccharide antigen in Shigella dysenteriae type 1 infection.
Sinha AK; Bhattacharya SK; Saha MR; Bhattacharya MK; Sen D; Ghosh AC; Pal SC
Indian J Med Res; 1988 Jul; 88():1-6. PubMed ID: 3053437
[No Abstract] [Full Text] [Related]
17. Production, characterization and immunodiagnostic application of a monoclonal antibody to Shiga toxin.
Qadri F; Mohi MG; Azim T; Faruque SM; Kabir AK; Albert MJ
J Diarrhoeal Dis Res; 1996 Jun; 14(2):95-100. PubMed ID: 8870402
[TBL] [Abstract][Full Text] [Related]
18. Safety and immunogenicity of Shigella sonnei-CRM9 and Shigella flexneri type 2a-rEPAsucc conjugate vaccines in one- to four-year-old children.
Passwell JH; Ashkenazi S; Harlev E; Miron D; Ramon R; Farzam N; Lerner-Geva L; Levi Y; Chu C; Shiloach J; Robbins JB; Schneerson R;
Pediatr Infect Dis J; 2003 Aug; 22(8):701-6. PubMed ID: 12913770
[TBL] [Abstract][Full Text] [Related]
19. Serologic response of patients with shiga dysentery.
Cáceres A; Mata LJ
J Infect Dis; 1974 Apr; 129(4):439-43. PubMed ID: 4593873
[No Abstract] [Full Text] [Related]
20. Monoclonal antibodies specific for Shigella flexneri lipopolysaccharides: clones binding to type IV, V, and VI antigens, group 3,4 antigen, and an epitope common to all Shigella flexneri and Shigella dysenteriae type 1 stains.
Carlin NI; Lindberg AA
Infect Immun; 1987 Jun; 55(6):1412-20. PubMed ID: 2437036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
